Skip to main content
. 2021 May 7;22(9):4981. doi: 10.3390/ijms22094981
AJCC American Joint Committee on Cancer
ASCO American Society of Clinical Oncology
bTMB Blood tumor mutational burden
CI Confidence interval
CPS Combined positive score.
CTLA4 Cytotoxic T lymphocyte Antigen 4
DFS Disease free survival
EMA European Medicines Agency
FDA Food and Drug Administration
HNSCC Head and neck squamous cell carcinoma
HPV Human papilloma virus
HR Hazard ratio
IC Investigators choice
IHC Immunohistochemical staining
IS Immunoscore
ISH In situ hybridization
Mb Megabase
NCI National Cancer Institute
NGS Next generation sequencing
OPSCC Oropharyngeal squamous cell carcinoma
OS Overall survival
PCR Polymerase chain reaction
PD-1 Programmed Cell Death Protein 1
PD-L1 Programmed death ligand-1
RSI Radiosensitivity Index
SOC Standard of car
TILs Tumor infiltrating lymphocytes
TMB Tumor mutational burden
TME Tumor microenvironment
TNM Tumor, node, metastasis
TPS Tumor proportion score
Tregs Regulatory T-cells
UICC Union for International Cancer Control
US United States